PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
ARTV Artiva Biotherapeutics
- 4.440
- +0.430+10.72%
Close Feb 14 16:00 ET
- 4.440
- 0.0000.00%
Post 20:01 ET
107.84MMarket Cap-1.76P/E (TTM)
4.570High3.990Low51.02KVolume3.990Open4.010Pre Close223.01KTurnover1.18%Turnover RatioLossP/E (Static)24.29MShares17.31052wk High0.54P/B19.19MFloat Cap3.37052wk Low--Dividend TTM4.32MShs Float17.310Historical High--Div YieldTTM14.46%Amplitude3.370Historical Low4.370Avg Price1Lot Size
Artiva Biotherapeutics News
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Baker Daniel G.
Artiva Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Baker Daniel G.
Artiva Biotherapeutics | 8-K: Current report
Artiva Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%), etc.
Artiva Biotherapeutics | 10-Q: Quarterly report
Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 8-K: Current report
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Raymon Heather
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graef Thorsten
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horan Christopher
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bush Jennifer
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnamohan Neha
Artiva Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%), etc.
Artiva Biotherapeutics | 10-Q: Quarterly report
Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Andrew J. Schwab(10.1%),Kush Parmar(10.1%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%), etc.
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call